Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000233129 is a **pseudogene** in the human genome, annotated based on sequence similarity to a portion of the NADH dehydrogenase 2 gene. The designation "pseudogene similar to part of NADH dehydrogenase 2" indicates lack of protein-coding potential and absence of known biological or pharmacological function. Pseudogenes result from duplication or retrotransposition events and typically lack transcriptional or translational activity. This gene is neither a receptor, enzyme, transporter, nor any other type of functional molecular target. It is not considered relevant for drug discovery, diagnostic biomarker development, or therapeutic intervention. Therefore, structured target and disease information, as would be collected for pharmacologically relevant genes, does not apply[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudogene similar to part of NADH dehydrogenase 2 (ENSG00000233129).